Instead, by improving weight, insulin resistance and inflammation, they may create a more favorable environment for the eggs and the uterine lining
Gallbladder and biliary disease: GLP-1based therapies have been associated with an increased risk of gallbladder problems, including gallstones and cholecystitis
Zhang H, Ni L, Liu Y, Wang Y, Zhang A, Tan M, et al
Combining these treatments with semaglutide could increase the chance of side effects, so its essential to inform healthcare providers about all medications being taken
Several areas warrant medical oversight
Ozempic: Subcutaneous injection approved by the FDA on December 5, 2017, to lower blood sugar in people with type 2 diabetes and off-label for weight loss in people with obesity and overweight